ERBB2 and neoplasm: Tumor size, ER status, HER2 status, and grade were each prognostic for 7-year RFS (Figure 1), confirming that the combined dataset shows the expected outcomes for known biomarkers, and suggesting that the gene expression-based HER2 status designation (see Methods) was performing appropriately.